Hitesh Kumar Dewangan

28PUBLICATIONS
8CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NeurogeneticsBiologically active moleculesBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 15, 2026
Targeted Therapeutics in Breast Cancer: Promise, Progress, and the Challenge of Triple-negative Subtype.

|Aug 21, 2026
Molecular pathways and emerging therapeutic strategies in advanced thyroid cancer: from targeted therapy to precision oncology.

|May 19, 2026
Understanding Huntington's Disease: Epidemiology, Mechanisms, and Modeling Approaches.

|May 15, 2026
Mechanistic Insights into Terpenoid-Based Therapy for Parkinson's Disease.

|Mar 28, 2026
Human Serum Albumin-coated macromolecular niosomes for enhanced immunotherapeutic efficacy in rheumatoid arthritis: optimization, characterization and in-vivo assessment.

Laxmi Rani, Ashwini Kumar Mishra, Neha S L

|Mar 15, 2026
Dual-Targeted Antiemetic Strategy: A Review of Granisetron-Scopolamine Transdermal Patch for PONV and CINV Management.

Ashim Kumar Sarkar, Kamal Shah, Hitesh Kumar Dewangan

Pageof 5

Frequent Collaborators

2 joint publications

Alok Nath Sharma

1 joint publications

Bhupesh C Semwal

1 joint publications

Prabhat Kumar Upadhyay

1 joint publications

Prabhat Kumar Upadhyay